Streamex Corp. (STEX) Company Overview

Streamex Corp. is a Nasdaq Capital Market company trading under STEX. Its current strategy is to build regulated infrastructure for tokenized real-world assets, beginning with commodity-linked securities. The flagship product is GLDY, a security designed to combine ownership exposure to physical gold with a yield generated by institutional gold leasing. The company also retains the PURE EP biomedical signal-processing platform from its former identity as BioSig Technologies.

Two businesses sit inside one reporting segment

The 2025 Form 10-K describes two principal business lines but only one reportable segment because management reviews consolidated results. That accounting presentation can obscure the strategic difference between the businesses: tokenization is the growth thesis, while PURE EP is a legacy regulated-medical-technology asset under strategic review.

PURE EP received FDA 510(k) clearance in August 2018. At year-end 2025, its portfolio included 46 issued or allowed utility patents and 30 pending U.S. and foreign utility applications. Any value should be estimated separately from tokenization.

Streamex intends to earn at issuance, during a token’s life and when it transfers. The commercial test is whether outside investors and commodity sponsors place enough assets on the platform to create recurring fees.

The fee architecture is plausible, but realized revenue is absent

The May 2026 corporate presentation presents these fee streams as long-duration management scenarios, not audited economics. Observed take rates should replace illustrative assumptions once revenue appears.

The quarter ended March 31, 2026 shows a company that raised capital, eliminated convertible debt and launched GLDY, but did not yet generate revenue. The Q1 2026 Form 10-Q is therefore better read as a capitalization and build-out report than as a normal operating quarter.

Cash moved from financing into debt repayment, securities and gold

The January 2026 public offering produced approximately $37.2 million of net proceeds. Streamex then repaid about $38.5 million of secured convertible debentures and redeployed capital into marketable securities, gold and platform development.

Debt risk fell and liquid assets remained meaningful, but both cash spending and equity compensation were substantial costs of establishing the platform.

GLDY is issued through Streamex Ltd., a Cayman Islands special-purpose entity consolidated as a variable interest entity. Its gold supports token obligations and may enter leases administered by Monetary Metals. Reserve integrity, redemption mechanics and lease-counterparty performance are therefore central operating metrics.

Reserve evidence is a credibility asset, not proof of mass adoption

independent reserve attestation reported 3,064.674268 redeemable tokens and 3,064.915910 fine troy ounces of redemption assets as of March 31, 2026, with an unmodified opinion. Attestations reduce information asymmetry but do not remove custody, settlement or lease risk.

Monthly distributions show the mechanism operating

The June 2026 distribution announcement stated that each token was earning a 3.9% annualized yield and holders received 0.003237 GLDY per token. Yield can vary with the amount and terms of gold deployed into leases.

Streamex is the product of a rapid transformation from medical technology to commodity tokenization. That history explains its unusual mix of biomedical patents, blockchain infrastructure, gold inventory and exchangeable shares.

1. 2018
   PURE EP received FDA 510(k) clearance, creating the regulated clinical asset retained today.
2. April 2024
   Streamex Exchange was incorporated in British Columbia to pursue blockchain-enabled commodity finance.
3. May 2025
   BioSig acquired Streamex Exchange and issued roughly 109.1 million exchangeable shares, shifting economic influence to the acquired company’s owners.
4. September 2025
   The Monetary Metals partnership, corporate rename and STEX ticker made commodity tokenization the formal strategy.
5. December 2025
   Streamex acquired a strategic Empress Royalty stake and expanded its gold position; the Empress investment was sold in January 2026.
6. January–February 2026
   A $40.25 million gross equity offering supported debt elimination and development; GLDY launched February 25.
7. April–July 2026
   Yield distributions, reserve attestation, brokerage distribution and a repurchase authorization shifted the story toward execution.

The acquisition changed both strategy and capital structure

During Q1 2026, 24,571,166 exchangeable shares converted into common stock. Offering shares, debt conversions and compensation lifted common shares outstanding to 97,721,696 at March 31, 2026, from 49,805,275 at year-end 2025.

The proposed advantage is integration. Streamex is attempting to connect commodity sourcing, legal structuring, token issuance, reserve verification, regulated distribution, custody and secondary-market access. A single product that combines gold exposure, monthly yield and familiar brokerage access could be more convenient than holding bullion while separately arranging lending or derivatives.

Partnerships substitute for owned scale

Monetary Metals supplies gold-leasing administration; tZERO provides regulated digital-securities custody and market infrastructure; Siebert adds a traditional brokerage channel. The June 2026 Siebert and tZERO collaboration cited approximately $20 billion in assets across Siebert’s network. That expands potential reach, but distribution capacity is not the same as funded GLDY balances.

The moat is currently contractual and architectural, not scale-based

These ratings summarize disclosed facts rather than credit quality. The contractual moat remains execution-dependent: Monetary Metals exclusivity requires Streamex to supply at least 10% of qualifying leased ounces each quarter, subject to a cure period.

Streamex’s balance sheet improved in one important respect during Q1 2026: secured convertible debt was eliminated. However, the company remains pre-revenue, spent $10.2 million in operating cash during the quarter and holds a large portion of its assets in goodwill, intangibles, marketable securities and gold rather than unrestricted cash.

Asset quality matters more than the headline total

Liquidity improved, but runway still depends on disciplined spending

Management concluded that resources were sufficient for at least one year from the Q1 filing date. The July 2026 repurchase program permits, but does not require, purchases of up to 10 million shares at no more than $2.00 per share. That discretion must be weighed against runway needs.

Streamex’s ownership is founder-influenced and complex. The 2025 proxy included common stock, exchangeable shares and securities exercisable within 60 days. Later conversions and issuances make the percentages historical governance markers.

The 2025 definitive proxy statement provides the historical voting-power figures shown above; later conversions and issuances changed the capitalization.

Governance quality must be judged alongside rapid issuance

The proxy described a classified board and independent key committees. Because Q1 stock-based compensation and shares issued for services reached $25.4 million, future awards should be judged against external AUM, revenue, cash-flow and compliance milestones.

Streamex’s risks are connected: weak adoption extends cash burn, cash burn can force issuance, and pressure to scale can increase regulatory, custody and counterparty exposure.

Where could upside come from?

The clearest opportunity is to convert GLDY from a company-funded demonstration into an externally funded product, then reuse the legal, compliance and technical stack for additional commodities.

Which risks are most material?

Gold is collateral and product inventory, not equivalent to cash

Gold supports GLDY but may sit in the SPV, back redemptions or be deployed in leases. Runway analysis should therefore separate unrestricted cash and liquid securities from product-backing assets.

A conventional DCF needs observable revenue and margins. Streamex has neither at commercial scale. FY2025 revenue was zero, total assets were $187.5 million and the $462.8 million net loss included a $389.7 million derivative-liability fair-value change plus $57.1 million of stock compensation. Historical margins are not a useful steady-state base.

A scenario model is more defensible than a single forecast

Value the pieces separately: probability-weight the platform, assess backing gold with its obligations, count liquid securities for runway and treat PURE EP as distinct optionality. Goodwill and acquired intangibles are not cash.

The next decisive evidence will come from operating disclosures rather than another product description. Streamex needs to show that external capital enters the platform, fees appear in revenue, expenses normalize and dilution slows.

A useful quarterly bridge would reconcile token balances, external subscriptions, redemptions, gold leased, yield earned, fees retained and ending reserves.

Streamex is attempting to turn gold into a regulated, digitally transferable security that pays gold-denominated yield. Independent reserve evidence, monthly distributions and the Siebert–tZERO channel support the concept; debt elimination improved the capital structure.

The counterweight is a pre-revenue income statement, minimal outside GLDY ownership at Q1 2026 quarter-end, significant cash use, rapid share issuance and material control weaknesses. The decisive test is whether unaffiliated capital creates recurring fees before further dilution becomes necessary.